Extensive vaccination programs have been performed around the globe to mitigate the effects of COVID-19.
1,2 However, the progressive waning of vaccine-induced protection
3-5 and the rapid replacement of the SARS-CoV-2 Delta variant by the Omicron variant in late 2021 to early 2022 have been associated with a marked increase of breakthrough infections among vaccinated individuals.
6-8 In particular, Omicron seems to be characterized by both a lower initial vaccine effectiveness (VE) and a faster waning of protection against infection. Several studies
9-48 have quantified the waning of VE against SARS-CoV-2 infection and symptomatic disease, but the obtained estimates are hard to reconcile because of differences in study design and temporal end points. Putting together the bulk of available evidence on the waning of VE over time against COVID-19 variants has crucial implications for future interventions and vaccination programs. A solid mathematical description of temporal changes in VE may have extensive applications for epidemic models. Various decay functions have been proposed for the COVID-19 VE waning rate in modeling studies
49-53 but not within a comprehensive framework comparing the available published evidence.